Related Experiment Video
Updated: Jun 24, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.
Jane Marian Anderson1, Rickie Patani, Richard Reynolds
1Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK.
Abnormal tau hyperphosphorylation occurs in early multiple sclerosis (MS) but remains soluble. Insoluble tau accumulation may be linked to later stages of MS disease progression.
Area of Science:
- Neuroscience
- Neuropathology
- Neuroimmunology
Background:
- Multiple sclerosis (MS) is characterized by neurodegeneration, but its mechanisms remain unclear.
- Abnormal tau hyperphosphorylation is associated with neurodegenerative diseases.
- Previous research linked insoluble tau to secondary progressive MS.
Observation:
- Examined tau phosphorylation in brain tissue from an early, aggressive MS case.
- Observed tau hyperphosphorylation across various cell types.
- Biochemical analysis confirmed tau was primarily in the soluble fraction.
Findings:
- Tau hyperphosphorylation was present in early MS.
- Sarcosyl-insoluble tau was absent in early disease stages.
- Soluble tau hyperphosphorylation was detected in early aggressive MS.
Implications:
- Suggests a potential temporal relationship between tau pathology and MS progression.
- Highlights the importance of soluble tau in early MS.
- Further research into tau's role in MS pathogenesis is warranted.
More Related Videos
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
12:47Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Multiple Sclerosis l: Introduction